TRGM — Targeted Medical Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.19m
- $5.26m
Annual cashflow statement for Targeted Medical Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.18 | -9.59 | -9.34 | -3.9 | -3.07 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.4 | 7.8 | 0.967 | 1.08 | 0.445 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.2 | 2.16 | 0.246 | 3.2 | 1.11 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -2.59 | -2.37 | -2.05 | 0.78 | -1.28 |
| Capital Expenditures | -0.512 | -0.295 | -0.121 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.244 | 0 | — | — | — |
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.268 | -0.295 | -0.121 | 0 | — |
| Financing Cash Flow Items | 0.603 | -0.268 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.2 | 2.85 | 2.33 | -1.26 | 1.35 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.649 | 0.179 | 0.165 | -0.48 | 0.071 |